A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

Neoadjuvant PD-1 blockade with dostarlimab achieved high rates of organ preservation in patients with early-stage mismatch ...

The dipeptidyl peptidase 1 (DPP-1) inhibitor cut the annualized rate of pulmonary exacerbations by around 20% compared with ...

Hydrazine (N2H4) is a highly toxic organic amine that can spontaneously ignite or explode when exposed to strong oxidants, ...

The 16-inch HP Envy 2-in-1 looks fairly ordinary at first, but opens way beyond the 120 degrees or so that you’re used to, flipping its screen all the way around back. When completely flipped to ...

A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a group of drugs used to treat type 2 diabetes and sometimes obesity. GLP-1 RAs are very effective at lowering blood sugar levels.

Use of a neoadjuvant checkpoint inhibitor enabled a high proportion of patients with early-stage mismatch repair-deficient ...

Glycomine has bagged a $115 million series C round to continue the progress of its lead candidate through phase 2 development ...

The best 2-in-1 laptops are my favorite laptops to review because they're designed to function as both a laptop and a tablet, so they're incredibly versatile. My team and I review dozens and ...

There are currently no FDA-approved treatments for FAP, a condition characterized by the proliferation of polyps in the colon and/or rectum.